Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Big Is The Actinic Keratosis Treatment Market Today And What Is Its Future Size?
The market size for the treatment of actinic keratosis has experienced significant growth in the past years. It is projected to increase from $3.2 billion in 2024 to $3.41 billion in 2025, with a compound annual growth rate(CAGR) of 6.6%. Factors contributing to this growth during the historical period revolve around adherence to treatment, competitive market activities, educational initiatives for patients, dermatological practices and the progress made in research and clinical trials.
In the forthcoming years, the market for actinic keratosis treatment is predicted to undergo significant expansion. The prediction is for a rise to $4.59 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 7.7%. This expansion over the forecast period can be credited to factors like patient enlightenment and participation, digital health amalgamation, rising consciousness, emphasis on preventive dermatology, and the trend towards personalized medicine. Key trends over this period consist of a shift to combination treatments, advancements in technology, customized treatment methodologies, growing incidence rates, and a preference for minimally invasive treatments.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8283&type=smp
Which Demand Drivers Are Strengthening The Actinic Keratosis Treatment Market?
The rise in the occurrence of actinic keratosis is anticipated to propel the expansion of the actinic keratosis treatment market in the future. Actinic keratosis, a rough, scaly skin condition, often occurs due to prolonged exposure to the sun. Its treatment plays a vital role in early identification and treatment of precancerous lesions, thereby lessening their potential risk. The escalated prevalence of actinic keratosis has subsequently boosted the demand for its treatment products, proposed medications under study, and the suggested use of topical treatments. As per an article by World Cancer Research Fund International, a UK-based organization, in February 2022, actinic keratosis cases rose from over 150,000 in 2020 to 197,700 cases in 2022. As a result, the escalating occurrence of actinic keratosis is acting as a growth catalyst for the actinic keratosis treatment market.
Which Segment Accounts For The Largest Share In The Actinic Keratosis Treatment Market?
The actinic keratosis treatmentmarket covered in this report is segmented –
1) By Treatment: Topical Treatment; Procedural Modality; Photodynamic Therapy; Other Treatments
2) By Medication: Fluorouracil Cream; Imiquimod Cream; Ingenol Mebutate Gel; Diclofenac Gel
3) By End User: Hospitals; Private Dermatology Clinics; Laser Therapy Centers; Cancer Treatment Centers; Spas And Rejuvenation Centers; Homecare
Subsegments:
1) By Topical Treatment: 5-Fluorouracil (5-FU); Imiquimod; Ingenol Mebutate; Diclofenac
2) By Procedural Modality: Cryotherapy; Curettage And Electrosurgery; Laser Therapy; Chemical Peels
3) By Photodynamic Therapy: ALA-Based PDT; MAL-Based PDT
4) By Other Treatments: Immunotherapy; Phototherapy; Combination Therapies
Which Disruptive Trends Are Driving Change Across The Actinic Keratosis Treatment Market?
Key players in the actinic keratosis treatment market are increasingly focusing on creating innovative product offerings such as prescription drugs to improve treatment effectiveness and patient outcomes. The drugs available only through a written prescription from a healthcare provider consist of specific details like the drug’s name, dosage, and duration. Such medicines are tailored for individual medical conditions and need close monitoring due to potential side effects. For instance, Biofrontera AG, a pharmaceutical firm based in Germany, introduced a new product, Ameluz, in December 2022. This topical gel contains 5-aminolevulinic acid, which, when used together with photodynamic therapy (PDT), can treat mild to moderate actinic keratoses (AK) and some basal cell carcinomas. The therapy involves the application of the gel on the skin areas affected, and then light from a BF-RhodoLED lamp is exposed to the skin to activate the medication.
Which Companies Hold A Competitive Edge In The 83 Market?
Major companies operating in the actinic keratosis treatment market are Sun Pharmaceutical Industries Ltd., Novartis AG, Hill Dermaceuticals Inc., Bausch Health Companies Inc., LEO Pharma A/S, Almirall SA, Biofrontera AG, Galderma SA, Mylan NV, Cipher Pharmaceuticals Inc., Pierre Fabre Pharmaceuticals Inc., Tolmar Pharmaceuticals Inc., Stanford Chemicals Company, Glaxo Smith Kline PLC, Alma Lasers Ltd., 3M Company, Nestle SA, Cutanea Life Sciences Inc., DUSA Pharmaceuticals Inc., Foamix Pharmaceuticals Ltd., G&W Laboratories Inc., Hikma Pharmaceuticals PLC, Innocutis Holdings LLC, Mayne Pharma Group Limited, Meda AB, Merz Pharma GmbH & Co KGaA, Perrigo Company PLC, PharmaDerm A division of Fougera Pharmaceuticals Inc., Promius Pharma LLC, Ranbaxy Laboratories Limited, Sandoz International GmbH, Stiefel Laboratories Inc., Teva Pharmaceutical Industries Ltd., Valeant Pharmaceuticals International Inc., Zydus Pharmaceuticals Inc., Dermira Inc., Menlo Therapeutics Inc., Sol-Gel Technologies Ltd., Verrica Pharmaceuticals Inc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/actinic-keratosis-treatment-global-market-report
Which Region Is Forecasted To Lead The Actinic Keratosis Treatment Market In The Coming Years?
North America was the largest region in the actinic keratosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the actinic keratosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=8283&type=smp
Browse Through More Reports Similar to the Global Actinic Keratosis Treatment Market 2025, By The Business Research Company
Lotions Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/lotions-global-market-report
Skin Care Products Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/skin-care-products-global-market-report
Dermatology Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model